Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the “Company”), an
industry leader in exoskeleton technology for medical and
industrial use, today announced that the Nebraska Chapter of the
Fraternal Order of Eagles (“F.O.E.”), an international nonprofit
community organization, has purchased two EksoNR devices on behalf
of local Nebraska inpatient rehabilitation facilities.
The EksoNR devices will be donated to the
Inpatient Rehabilitation Unit at Bryan Medical Center, a 30-bed
unit in Lincoln, Neb., and Nebraska Methodist Hospital &
Rehabilitation Center’s 22-bed rehabilitation facility in Omaha,
Neb. More than 60% of the typical patient population at both
facilities stand to benefit from EksoNR’s leading
neurorehabilitation solutions.
“Ekso Bionics is proud to partner with the
Fraternal Order of Eagles in improving outcomes for patients
through our innovative EksoNR technology,” said Bill Shaw, Chief
Commercial Officer of Ekso Bionics. “With EksoNR devices placed at
multiple Nebraska locations that have a deep focus on
neurorehabilitation, an increasing number of physical therapists
will have necessary tools to elevate the standard of care for
neurorehabilitation with our groundbreaking exoskeleton.”
“Supporting patients with spinal cord injury is
one of the Fraternal Order of Eagles’ primary initiatives, and we
take pride in this endeavor,” said F.O.E. Grand Worthy President
Brian Rogers. “The F.O.E. already has a great relationship with
Ekso Bionics, whom we selected as a partner for this donation as a
result of the technology’s successful adoption in the Nebraska
market and compelling patient stories.”
“The addition of EksoNR into our rehabilitation
unit enables us to continue to provide superior care by bringing
the most advanced solutions to our patients,” said Sarah Cockle,
the Service Leader for Therapy Services at Nebraska Methodist
Hospital & Rehabilitation Center. “EksoNR features unique
capabilities that deliver superior outcomes for patients recovering
from stroke, spinal cord injuries and traumatic brain injuries, all
of which we serve at Methodist Hospital. We are excited to
incorporate the most advanced exoskeleton robotics into our rehab
programs.”
“We are grateful for the use of EksoNR through
the generous donation of the Nebraska Chapter of the Fraternal
Order of Eagles,” said Samantha Penas, assistant therapy manager at
Bryan Medical Center. “The EksoNR provides us with additional
advanced technology to maximize functional recovery and promote
patient independence. Our expert team looks forward to including
this technology into our collaborative rehab approach for stroke,
brain and spinal cord injuries.”
EksoNR is the most clinically used robotic
exoskeleton designed to be used in a rehabilitation setting to
progress neurorehab patients to learn to walk again with a more
natural gait. The device is the first exoskeleton FDA-cleared for
acquired brain injury, stroke, and spinal cord injury, that
re-teaches the brain and muscles how to properly walk again.
To find a location with EksoNR near you,
visit eksobionics.com/centers.
About Ekso Bionics®Ekso
Bionics® is a leading developer of exoskeleton solutions that
amplify human potential by supporting or enhancing strength,
endurance and mobility across medical and industrial applications.
Founded in 2005, the Company continues to build upon its
industry-leading expertise to design some of the most cutting-edge,
innovative wearable robots available on the market. Ekso Bionics is
the only exoskeleton company to offer technologies that range from
helping those with paralysis to stand up and walk, to enhancing
human capabilities on job sites across the globe. The Company is
headquartered in the San Francisco Bay Area and is listed on the
Nasdaq Capital Market under the symbol “EKSO.” For more
information, visit: www.eksobionics.com or follow @EksoBionics on
Twitter.
About Fraternal Order of
Eagles
The Fraternal Order of Eagles, an international
nonprofit organization, unites fraternally in the spirit of
liberty, truth, justice and equality, to make human life more
desirable by lessening its ills, and by promoting peace,
prosperity, gladness and hope. The F.O.E. donates more than $10
million a year to local communities, fundraisers, charities and
more. As part of its philosophy, the F.O.E. gives back 100 percent
of monies raised in the form of grants. Fundraisers are conducted
for eight major charities, including kidney, heart, diabetes,
cancer and spinal cord injury funds, a children's fund, memorial
foundation and the Golden Eagle Fund.
About Bryan Medical Center
Bryan Medical Center is a locally owned and
governed nonprofit medical center located in Lincoln, Neb. Bryan is
designated as a Level II Trauma Center. The Inpatient
Rehabilitation Unit at Bryan Medical Center is a 30-bed unit
specializing in stroke, brain injury, and spinal cord injury
rehabilitation. Their expert team has achieved the highest level of
recognition by the Commission on Accreditation of Rehabilitation
Facilities (CARF). Bryan prides itself on returning 85 percent of
patients back home. Their patient outcomes meet and exceed those of
other facilities regionally and nationally.
About Methodist Hospital
With more than 2,000 full-time employees and
more than 400 physicians on active staff, Methodist Hospital has a
tradition of providing quality health care to the region in
cardiovascular surgery, neurosurgery, women’s services, cancer
care, gastroenterology, orthopedics, and comprehensive diagnostic
services. Founded in 1891 by members of the Methodist Church in
Omaha, Neb., Methodist Hospital is a not-for-profit, 423-bed, acute
care hospital serving the metropolitan-Omaha area.
Forward-Looking StatementsAny
statements contained in this press release that do not describe
historical facts may constitute forward-looking statements.
Forward-looking statements may include, without limitation,
statements regarding the plans, objectives and expectations of
management with respect to the Company’s commercial strategy and
future revenues or other financial results and the assumptions
underlying or relating to the foregoing. Such forward-looking
statements are not meant to predict or guarantee actual results,
performance, events or circumstances and may not be realized
because they are based upon the Company's current projections,
plans, objectives, beliefs, expectations, estimates and assumptions
and are subject to a number of risks and uncertainties and other
influences, many of which the Company has no control over. Actual
results and the timing of certain events and circumstances may
differ materially from those described by the forward-looking
statements as a result of these risks and uncertainties. Factors
that may influence or contribute to the inaccuracy of the
forward-looking statements or cause actual results to differ
materially from expected or desired results may include, without
limitation, the Company's inability to obtain adequate financing to
fund the Company's operations and necessary to develop or enhance
the Company’s technology, the significant length of time and
resources associated with the development of the Company's
products, the Company's failure to achieve broad market acceptance
of the Company's products, the failure of the Company’s sales and
marketing efforts or of partners to market the Company’s products
effectively, adverse results in future clinical studies of the
Company's medical device products, the failure of the Company to
obtain or maintain patent protection for the Company's technology,
the failure of the Company to obtain or maintain regulatory
approval to market the Company's medical devices, lack of product
diversification, existing or increased competition, disruptions in
the Company’s supply chain due to the outbreak of the COVID-19
virus, and the Company's failure to implement the Company's
business plans or strategies. These and other factors are
identified and described in more detail in the Company's filings
with the SEC. To learn more about Ekso Bionics please visit the
Company’s website at www.eksobionics.com or refer to the Company’s
Twitter page at @EksoBionics. The Company does not undertake to
update these forward-looking statements.
Investor Contact:David
Carey212-867-1768investors@eksobionics.com
Media Contact:Erich
Sandoval917-497-2867Erich.Sandoval@finnpartners.com
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Apr 2023 to Apr 2024